FDA Expected To Approve Esketamine Nasal Spray For Depression

By Jon Hamilton
Published March 4, 2019 at 5:41 PM MST
  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Flipboard

Your browser doesn’t support HTML5 audio

The Food and Drug Administration is expected to approve a new type of drug for depression. It is esketamine, a chemical cousin of the anesthetic and party drug ketamine.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Flipboard
Jon Hamilton
Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks.
See stories by Jon Hamilton
Make a Donation